Key result
Sub-neutralising dilutions of specific antisera delayed the onset of FMDV-induced cytopathic effect by up to 44 hours compared to untreated controls, driving viral adaptation and mutations.
Why the study?
Viruses can evolve under immune pressure from specific antibodies, prompting the development of an in vitro system to investigate how serum-neutralising antibodies impact the evolution of a foot-and-mouth disease virus isolate.
An in vitro system demonstrates that FMDV can rapidly adapt to escape immune pressure from sub-neutralising antibodies via specific mutations in known epitope sites.
Sub-neutralizing antisera may drive FMDV adaptation in vitro; hypothesis-generating and leaves open implications for vaccine strategies.
Viruses can evolve to respond to immune pressures conferred by specific antibodies generated after vaccination and/or infection. In this study, an in vitro system was developed to investigate the impact of serum-neutralising antibodies upon the evolution of a foot-and-mouth disease virus (FMDV) isolate. The presence of sub-neutralising dilutions of specific antisera delayed the onset of virus-induced cytopathic effect (CPE) by up to 44 h compared to the untreated control cultures. Continued virus passage with sub-neutralising dilutions of these sera resulted in a decrease in time to complete CPE, suggesting that FMDV in these cultures adapted to escape immune pressure. These phenotypic changes were associated with three separate consensus-level non-synonymous mutations that accrued in the viral RNA-encoding amino acids at positions VP266, VP280 and VP1155, corresponding to known epitope sites. High-throughput sequencing also identified further nucleotide substitutions within the regions encoding the leader (Lpro), VP4, VP2 and VP3 proteins. While association of the later mutations with the adaptation to immune pressure must be further verified, these results highlight the multiple routes by which FMDV populations can escape neutralising antibodies and support the application of a simple in vitro approach to assess the impact of the humoral immune system on the evolution of FMDV and potentially other viruses.
No takes yet. Share an insight, caveat, or question.
King et al. (2022) studied Foot-and-mouth disease virus (FMDV) evolution. Sub-neutralising dilutions of specific antisera vs. Untreated control cultures was evaluated on Time to complete virus-induced cytopathic effect (CPE) and viral mutations. Sub-neutralising dilutions of specific antisera delayed the onset of FMDV-induced cytopathic effect by up to 44 hours compared to untreated controls, driving viral adaptation and mutations.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: